Navigation Links
Prions Prevent Alzheimers Disease

A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified. It appears that the normal prions produced by the body help to prevent the plaques that build up in the brain to cause Alzheimers disease.

The possible function for the mysterious proteins was discovered by a team of scientists led by Medical Research Council funded scientist Professor Nigel Hooper of the University of Leeds.

Alzheimers and diseases like variant Creutzfeldt-Jakob Disease follow similar patterns of disease progression and in some forms of prion disease share genetic features. These parallels prompted Professor Hoopers team to look for a link between the different conditions. They found an apparent role for normal prion proteins in preventing Alzheimers disease.

Our experiments have shown that the normal prion proteins found in brain cells reduce the formation of beta-amyloid, a protein that binds with others to build plaques in the brain that are found in Alzheimers disease, explains Professor Hooper.

He continues: In vCJD, the normal version of prion protein, PrPc, found naturally in the brain is corrupted by infectious prions to cause disease. The normal function of PrPc has been unclear.

Using cells grown in the lab, the team looked at the effect of high and low levels of normal prion protein on the successful formation of beta amyloid, the source of Alzheimers plaques. They found that beta amyloid did not form in cells with higher than usual levels of PrPc. In comparison, when the level of PrPc was low or absent, beta amyloid formation was found to go back up again.

Mice genetically engineered to lack PrPc were also studied. Again, this revealed that in its absence, the harmful beta-amyloid proteins were able to form. It appears that PrPc, the normal prion protein, exerts its beneficial effect by stopping an enzyme called beta-secretase from cutting up amyloid protei n into the smaller beta-amyloid fragments needed to build plaques.

Further evidence for the protective role of normal prion proteins is provided by mutated versions that are linked to genetic forms of prion disease because beta-amyloid fragments are able to form when the normal prion protein is corrupted by genetic mutation.

Professor Hooper concludes: Until now, the normal function of prion proteins has remained unclear, but our findings clearly identify a role for normal prion proteins in regulating the production of beta-amyloid and in doing so preventing formation of Alzheimers plaques. Whether this function is lost as a result of the normal ageing process, or if some people are more susceptible to it than others we dont know yet.

The next step for our research will be to look in more detail at how the prion protein controls beta amyloid, knowledge that could be used to design anti-Alzheimers drugs. Theoretically, if we can find a way of mimicking the prions function we should be able to halt the progress of Alzheimers. However, theres still a lot of work to be done in looking at levels of prions in the human system and how these may alter as we age.


'"/>




Related medicine news :

1. Prions Capacity can Be Aggrevated by Solid Particles
2. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
3. Prevention is better than cure
4. Prevention of cataracts
5. Medications to Prevent Relapse to Cocaine Use
6. Estrogen Does Not Prevent Recurrent Strokes
7. Over-The-Counter Drugs May Prevent Alzheimers
8. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
9. Alcoholism Drug Fails To Prevent Drinking Relapses
10. Preventing mental decline in the aged
11. Preventing white coat hypertension
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, ... Sankyo) today announced preliminary safety and efficacy data ... investigational oral selective MDM2 inhibitor, suggesting that DS-3032 ... including relapsed/refractory acute myeloid leukemia (AML) and high-risk ... escalation part of the phase 1 study of DS-3032 ...
Breaking Medicine Technology: